Skip navigation

Global Health at R4D

Global Health

R4D leverages extensive networks and expertise to improve health and achieve equity in health outcomes for all people around the world. Whether it's assessing policies that can support research and development on new drugs and vaccines, exploring innovations in healthcare and connecting innovators to each other or to investors, supporting the growing global movement for universal health coverage, or producing on-demand research and forecasting to help countries and global institutions plan their healthcare futures, R4D’s global health work unlocks new possibilities for global health actors worldwide.

Featured Global Health Projects

The Center for Health Market Innovations (CHMI) promotes policies and practices that improve privately delivered health care for the poor in low- and middle- income countries. Operated through a global network of partners since 2010, CHMI is managed by Results for Development.

Global Health Projects

The Maternal and Child Survival Program is a global U.S. Agency for International Development (USAID) cooperative agreement to introduce and support high-impact health interventions in 24 priority countries with the ultimate goal of ending preventable maternal and child deaths within a generation.

Over the past two years, Nigeria has shown a renewed commitment to strengthening its health services, notably under the aegis of the Saving One Million Lives (SOML) initiative. 

Under-nutrition, which accounts for one-third of all child deaths, is the single largest contributor to child mortality worldwide. It also costs the global economy billions of dollars each year in health care expenditures and losses in productivity and earnings.

The Transparency for Development project is designed to investigate the questions of whether well-designed transparency and accountability interventions improve health outcomes and under what conditions. The overriding goal is to generate actionable evidence for practitioners, researchers, and other stakeholders working to improve health, accountability, and citizen participation.

Africa shoulders the brunt of the global AIDS burden: UNAIDS estimates that in 2009, 22.5 million people were living with HIV in Africa alone, and AIDS remains the major cause of death of women of reproductive age and adult men in sub-Saharan Africa. 

In 2011, 34 million people around the world were living with HIV, 1.7 million died from the disease, and an additional 2.5 million people were newly infected. Antiretroviral therapy (ART) for HIV slows the progression of the disease.

Severe acute malnutrition (SAM), or extremely low weight-for-height, is estimated to affect 500,000-1,000,000 children under age five in Nigeria every year, contributing to as many as 100,000 deaths per year. 

To address drawbacks in their rounds-based funding model, the GF Board decided in early 2012 to explore new options that might lead to more strategic investment of resources, focusing on highest-impact countries and allowing for greater predictability. 

In 2001, the World Health Organization (WHO) recommended the use of artemisinin-based combination therapies (ACTs) to treat malaria patients, replacing artemisinin monotherapies and other sub-standard drugs that have the potential to cause drug resistance.

At the London Family Planning Summit of 2012, governments, bilateral and multilateral donors, service providers, private sector companies and non-governmental organizations launched the Family Planning 2020 initiative (FP2020).

Currently, only 20% of the South African population has health insurance. Faced with tough problems of access, efficiency, quality, and equity in its health system, the country has embarked on an ambitious, 14-year strategy to join global efforts to achieve universal health coverage.

The global health sector has evolved dramatically over the past two decades, with the emergence of new organizations like the Bill and Melinda Gates Foundation and the GAVI Alliance accompanied by much higher volumes of funding. 

An estimated 34 million people are living with HIV around the world. Although significant progress has been made in fighting the epidemic, 2.5 million people became newly infected with HIV in 2011, while another 1.7 million died from AIDS.

The Health Finance and Governance project supports partner countries’ efforts to increase domestic resources available for health care, manage those resources more effectively, and improve the efficiency of purchasing decisions.

R4D is providing technical support to GAVI and the WHO to wean countries whose level of per capita income off of their assitance to purchase or introduce vaccines.

At PEPFAR's request, R4D and ICF International are developing and assessing options for financing medium-term AIDS plans for select PEPFAR countries based on what is fair, affordable, sustainable, and aligned with the preferences of the main funding sources.

India's National AIDS Control Organization (NACO) asked the Bill & Melinda Gates Foundation to back a program of modeling, analysis, and technical advisory work by R4D in support of NACO. R4D initiated this effort in mid 2011, with the goal of completing the work by the middle of 2012, in time to make an input to the formulation of the 2013-17 plan.

R4D is supporting The Public Health Foundation of India (PHFI) as a key technical partner in ensuring high quality analysis and recommendations on future health financing policy for India.

The Children's Investment Fund Foundation asked Results for Development Institute to develop frameworks for costing, cost-effectiveness analysis, and financial sustainability that the Foundation can use consistently across five CIFF priority areas: neonatal mortality, early childhood education, severe and acute malnutrition, prevention of mother-to-child transmission of HIV and de-worming.

GAVI commissioned the Results for Development Institute (R4D) to assist the GAVI Secretariat in reviewing its new vaccine introduction grant policy.

Starting in July 2010, the Global Fund requested technical input from R4D to design and assess new policy options. Working closely with the Global Fund’s Secretariat, R4D embarked on in-depth financial, health, and political analysis.

GAVI engaged R4D to carry out a major study on GAVI’s policies on “country eligibility." The project included an inception report, six country case studies, a technical brief on the pharmaceutical manufacturers' likely response to changes in GAVI eligibility policies, a model projecting the future financial requirements of the organization, and draft and final reports to GAVI.

The goal of this research initiative is to foster greater understanding of the factors influencing health spending in low and middle income countries, in an effort to assess further the economic feasibility of and imperative for universal health coverage (UHC).

UHC Forward consolidates information from hundreds of sources into a one-stop portal to keep visitors informed of health coverage efforts in countries around the world.

The Joint Learning Network (JLN) for Universal Health Coverage brings together countries from across the globe to share experiences and challenges in implementing health financing reforms.

Results for Development Institute (R4D) recently completed a study funded by the Bill & Melinda Gates Foundation on the challenges that Lower Middle Income Countries (LMICs) face as they consider the adoption of new vaccines.  

The Center for Global Health R&D Policy Assessment conducts R&D policy assessments based on extensive research and public consultations, and engages key stakeholders to facilitate the uptake of promising ideas.

The Center for Health Market Innovations (CHMI) promotes policies and practices that improve privately delivered health care for the poor in low- and middle- income countries. Operated through a global network of partners since 2010, CHMI is managed by Results for Development.

aids2031 is a international consortium of partners examining the future of the HIV/AIDS epidemic. The Costs and Financing Working Group is focused on modeling and analyzing the long-term costs and financing of the epidemic, and examining scenarios in which major policy shifts now can improve the future expenditure and financing situation.

The Role of the Private Sector in Health Systems project sought to advance thinking on the role of the private sector into health systems and develop a broad systems perspective on how public and private sectors can work together to address the challenges of affordability, quality, and availability of care.

The Ministerial Leadership Initiative for Global Health (MLI) brings together expertise in leadership development and specialized technical areas needed to design and successfully make and implement health sector policy. As a technical partner in MLI, R4D is providing technical assistance focused on improvements in equitable financing and donor harmonization in Ethiopia, Mali, Nepal, Senegal, and Sierra Leone.